• Activity INFORMATION

  Overview

  This session seeks to explore the role of the pharmacist in the management of patients with heart failure. Approximately 25% of hospitalized heart failure patients are readmitted within the first 30 days, often due to medication nonadherence, inadequate understanding of the disease and/or treatment, and the inability to recognize key signs of exacerbation. By categorizing medications as mortality and morbidity reducing agents, this session seeks to assist the pharmacist in exploring medications commonly used in the treatment of heart failure. Notable clinical trials are used as the foundation for best management practices for heart failure patients.
  

  Handouts

  • Slide Document :   20178H01_2pp.pdf Download

  • Slide Document :   20178H01_6pp.pdf Download

  Financial Support By

  PharmCon

• Learning OBJECTIVES

  Pharmacist

  Recognize notable results of clinical trials that serve as the basis for the current management of heart failure.

  Categorize medications as mortality- and/or morbidity-reducing agents for heart failure

  Identify the role of angiotensin receptor/neprilysin inhibitors (ARNIs) in heart failure.

  Describe the compensatory mechanisms that lead to cardiac remodeling and symptoms of heart failure

  Nurse

  Describe the compensatory mechanisms that lead to cardiac remodeling and symptoms of heart failure

  Recognize notable results of clinical trials that serve as the basis for the current management of heart failure.

  Identify the role of angiotensin receptor/neprilysin inhibitors (ARNIs) in heart failure.

  Categorize medications as mortality- and/or morbidity-reducing agents for heart failure

• Activity ACCREDITATION

  Activity Type

  Knowledge

  CE Broker

  20-802930

  Universal Activity Number

  Pharmacist 0798-0000-20-178-H01-P
  Nurse 0798-0000-20-178-H01-N
  

  PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

  PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

  In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

• Activity INSTRUCTION

  Faculty

  Zach  Weber, PharmD, BCPS, BCACP, CDE Clinical Associate Professor, Purdue University

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).